Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
Neonc Technologies, Inc.
Amgen
Var2 Pharmaceuticals
Vanderbilt University Medical Center
LigaChem Biosciences, Inc.
Telix Pharmaceuticals (Innovations) Pty Limited
Bayer
Shandong Cancer Hospital and Institute